interstitiallungdiseaseuptodate

由 TE King Jr 著作 · 被引用 19 次 — Approach to the adult with interstitial lung disease: Clinical evaluation. Formulary drug information for this topic.

由 TE King Jr 著作 · 被引用 7 次 — Approach to the adult with interstitial lung disease: Diagnostic testing. Formulary drug information for this topic.

由 LR Young 著作 · 被引用 4 次 — Approach to the infant and child with diffuse lung disease (interstitial lung disease). Formulary drug information for this topic.

由 LR Young 著作 · 被引用 4 次 — Classification of diffuse lung disease (interstitial lung disease) in infants and children. Formulary drug information for this topic.

由 J Varga 著作 · 被引用 4 次 — Clinical manifestations, evaluation, and diagnosis of interstitial lung disease in systemic sclerosis (scleroderma).

Connective tissue disorders and vasculitis. Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

由 PF Dellaripa 著作 · 被引用 3 次 — INTRODUCTION. Interstitial lung disease (ILD) is a major cause of morbidity and mortality in dermatomyositis (DM) and polymyositis (PM).

由 FR Lake 著作 · 被引用 17 次 — Outline · General measures · Deciding whom to treat · Patients with mild ILD or stable fibrotic disease · Initial therapy for more severe or ...

2024年2月8日 — Treatment and prognosis of interstitial lung disease in systemic sclerosis (scleroderma). Formulary drug information for this topic.